Holen Sie sich die Stockscreener-App
220.19
1.40%
3.63
Schlusskurs vom Vortag:
$216.56
Offen:
$215.75
24-Stunden-Volumen:
71,351
Relative Volume:
0.19
Marktkapitalisierung:
$4.88B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-8.0567
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
-4.67%
1M Leistung:
-7.08%
6M Leistung:
-33.91%
1J Leistung:
-24.00%
1-Tages-Spanne:
$211.43
$220.38
1-Wochen-Bereich:
$211.43
$233.28
52-Wochen-Spanne:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
220.38 | 6.27B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
132.82 | 231.29B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.93 | 157.07B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.46 | 146.67B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.25 | 104.07B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.94 | 44.71B | 5.54B | 4.18B | 623.10M | 7.00 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Cell Viability Assays Market 2025 | Techniques, Applications & - openPR.com
Gel Documentation Systems Market Projected to Witness Massive - openPR.com
High Resolution Melting Analysis Market Detailed in New - openPR.com
Cell Signaling Market in 2025-2032 Detailed Study Analysis with - openPR.com
Neuroscience Antibodies and Assays Market Trends, Growth & - openPR.com
Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com
Protein Characterization and Identification Market Is Booming WorldwideBio-Rad Laboratories, Agilent Technologies - openPR.com
Electrophoresis Reagents Market Detailed in New Research ReportBio-Rad Laboratories, Thermo Fisher Scientific - openPR.com
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference | BIO Stock News - GuruFocus
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference - Business Wire
Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com
Cell Analysis Market Deep Research Report Highlights New DevelopmentsBD Biosciences, Bio-Rad - openPR.com
Hemoglobin A1c Testing Devices Market To Witness Substantial - openPR.com
Difficult-to-Express Proteins Market Expansion Driven - openPR.com
Salmonella Testings Market to Witness Stunning Growth with Thermo Fisher, Bio-Rad, Merck - openPR.com
Flow Cytometry Market Deep Research with Forecast By 2025-2032 | - openPR.com
Protein Assays Market Set to Witness Significant Growth - openPR.com
Enzyme Linked Immunosorbent Assay Market Survey Detailed - openPR.com
Global Clinical Microbiology Market Trends, Growth & Analysis - openPR.com
Medical Biosensors Market 2025 | Latest Trends, Growth Forecast - openPR.com
Bio-Rad’s SWOT analysis: life science firm navigates tariffs, eyes growth - Investing.com Canada
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges - Investing.com Australia
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 01 - marketscreener.com
Bio-Rad Laboratories Inc (BIO) Stock Price Down 4.42% on May 21 - GuruFocus
Polymerase Chain Reaction Market Deep Research Report with - openPR.com
Multiplex assays Market Set to Witness Significant Growth - openPR.com
Protein Chip Industry Forecast: Clean Ingredients, - openPR.com
Bio-rad outlines updated 2025 guidance amid academic and macro challenges - MSN
Antibody and Protein Labeling Kits Market Outlook, Trends, Growth and Opportunities | Exactitude Consultancy - GlobeNewswire Inc.
Karyotype Market Size, Growth Analysis 2031 by Key Vendors- - openPR.com
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket - MSN
Cytogenetic Systems Market Accelerates Owing to Increased - openPR.com
RNA Analysis Transcriptomics Market Top PlayersAgilent - openPR.com
Polyclonal Antibody Market Growth, Trends & Forecast 2025-2033 - openPR.com
Syphilis Immunoassay Diagnostics Market Detailed in New - openPR.com
Serum Market Is Booming Worldwide 2025-2032 | Thermo Fisher - openPR.com
Multiplex Assays Market Is Booming Worldwide 2025-2032 | Bio-Rad Laboratories, Inc.,Thermo Fisher Scientific - openPR.com
Microplate Systems Market Experiencing Steady Growth - openPR.com
Vector Purification Market 2025: Growth, Applications, - openPR.com
Enzyme Linked Immunosorbent Assay Market Set to Witness - openPR.com
Digital PCR Market in Research By 2031 | Most Leading Companies - openPR.com
Onco-hematology Molecular Testing Market Top Players - openPR.com
Protein Engineering Market Detailed In New Research Report 2025 - openPR.com
Transfection Technologies Market Competitive Growth - openPR.com
Research Antibodies Market Is Booming So Rapidly 2025-2032 - openPR.com
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):